Major Funders and R&D Partners
Aeras research and development work is funded by key partners worldwide. Funding streams include grants from foundations and governments, investments from industry partners, and co-investments with other organizations, governments and institutions.
Donor support drives innovation by strengthening and advancing the global pipeline of new TB vaccines, accelerating efforts toward ensuring their availability to all who need them. Aeras thanks the following foundations and governmental organizations for their generous support: